President Joe Biden’s career-defining victories over Big Pharma — reforming Medicare to lower prices and capping inhaler costs for millions of Americans with lung disease — are facing an unlikely ...

Overuse of reliever inhalers is associated with higher risks of developing and dying from cardiovascular disease, including ...

Leah J. Witt, MD: Hello. I'm Dr Leah Witt. Welcome to season one of Medscape InDiscussion, chronic obstructive pulmonary disease (COPD) podcast series. Today we're talking medications, especially ...

EDITOR’S NOTE: Dr. Edith Bracho-Sanchez is a primary care pediatrician, director of pediatric telemedicine and assistant professor of pediatrics at Columbia University Irving Medical Center. Flovent, ...

Several major manufacturing plants for the asthma and respiratory drug Albuterol have shut down, possibly worsening an already-flaring shortage of the medication that has forced hospitals to devise ...

Adherium, the Australian connected inhaler company that partnered with AstraZeneca earlier this summer, has released data from three small studies of the company's Smartinhaler system. Data from the ...

Please provide your email address to receive an email when new articles are posted on . Digital inhaler data paired with expert-consensus thresholds on reliever medication use shows those who overuse ...

Asthma has been linked with adverse outcomes in both mothers and their offspring ...

Flovent, a commonly prescribed childhood medication for asthma, is no longer being made in the U.S. Smith Collection,Gado, Getty Images Editor's note: Dr. Edith Bracho-Sanchez is a primary care ...